191 filings
8-K
BCDA
BioCardia Inc.
27 Mar 24
BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results
4:07pm
8-K
BCDA
BioCardia Inc.
13 Mar 24
BioCardia and StemCardia Announce Biotherapeutic Delivery Partnership
7:00am
8-K
BCDA
BioCardia Inc.
12 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:33pm
8-K
BCDA
BioCardia Inc.
12 Mar 24
BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study
7:00am
8-K
BCDA
BioCardia Inc.
4 Mar 24
Regulation FD Disclosure
8:00am
8-K
v6b q50kw
9 Feb 24
Unregistered Sales of Equity Securities
9:58am
8-K
szywe2b
8 Feb 24
BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDA
7:03am
8-K
2fq5p1eic2tgi77nm
31 Jan 24
BioCardia Announces Two Scientific Abstracts Have Been Accepted at the 2024 Technology and Heart Failure Therapeutics Conference
7:00am
8-K
omtid5yd cu
3 Jan 24
Business Development Update for Shareholders
7:00am
8-K
l01f99 72gqtmaw6h
19 Dec 23
Other Events
7:00am
8-K
a7ius68 d8xtgna
18 Dec 23
BioCardia Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical and Medical Device Agency Consultation Minutes
7:00am
8-K
aft9rfgklincq
6 Dec 23
Other Events
6:05am
8-K/A
0nsrtd f77m
5 Dec 23
Submission of Matters to a Vote of Security Holders
4:11pm
8-K
jvh0hg48pffzypp3nzmn
5 Dec 23
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:05pm
8-K
l3h5w
29 Nov 23
Other Events
7:00am
8-K
tglizd
16 Nov 23
Securities Purchase Agreement
5:15pm
8-K
x718vn
14 Nov 23
BioCardia Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure
12:00am
8-K
p67 9k0lqmin
8 Nov 23
Biocardia Reports Third Quarter 2023 Business Highlights and Financial Results
4:08pm
8-K
x5tj1d ycr
18 Oct 23
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
qdt98z35vzhpwkrl zv
11 Oct 23
BioCardia Announces Completion of Enrollment in Phase III CardiAMP HF Trial and Plans for CardiAMP HF Trial II
6:04am